132 related articles for article (PubMed ID: 55505)
1. Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response.
Iacovino JR; Leitner J; Abbas AK; Lokich JJ; Snider GL
JAMA; 1976 Mar; 235(12):1253-5. PubMed ID: 55505
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin-associated pulmonary fibrosis: rapidly fatal progression without chest radiotherapy.
Dee GJ; Austin JH; Mutter GL
J Surg Oncol; 1987 Jun; 35(2):135-8. PubMed ID: 2438515
[TBL] [Abstract][Full Text] [Related]
3. Reversibility of severe bleomycin-induced pneumonitis.
Brown WG; Hasan FM; Barbee RA
JAMA; 1978 May; 239(19):2012-4. PubMed ID: 76689
[TBL] [Abstract][Full Text] [Related]
4. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1974.
N Engl J Med; 1974 Feb; 290(7):390-6. PubMed ID: 4129576
[No Abstract] [Full Text] [Related]
5. Role of carbon monoxide diffusing capacity in the early detection of major bleomycin-induced pulmonary toxicity.
Bell MR; Meredith DJ; Gill PG
Aust N Z J Med; 1985 Apr; 15(2):235-40. PubMed ID: 2411250
[TBL] [Abstract][Full Text] [Related]
6. Prolonged administration of bleomycin without clinical toxicity. Therapy with 2,700 units over four years.
Kurnick JE
Chest; 1977 Dec; 72(6):798-9. PubMed ID: 72636
[TBL] [Abstract][Full Text] [Related]
7. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
8. [Bleomycin-induced pulmonary fibrosis following chemotherapy of ovarian granulosa cell tumor].
Theile A; Kemper P
Pneumologie; 1998 Jun; 52(6):325-32. PubMed ID: 9715647
[TBL] [Abstract][Full Text] [Related]
9. Tallysomycin S10b--a phase I trial.
Sørensen PG; Pedersen H; Clausen HV; Hansen HH
Cancer Chemother Pharmacol; 1989; 24(2):113-6. PubMed ID: 2471602
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.
Luursema PB; Star-Kroesen MA; van der Mark TW; Sleyfer DT; Koops HS; Peset R
Am Rev Respir Dis; 1983 Nov; 128(5):880-3. PubMed ID: 6195947
[TBL] [Abstract][Full Text] [Related]
11. Controlled studies with bleomycin in solid tumors and lymphomas.
Bonadonna G; Tancini G; Bajetta E
Prog Biochem Pharmacol; 1976; 11():172-84. PubMed ID: 63961
[No Abstract] [Full Text] [Related]
12. Fatal interstitial pneumonitis induced by low dosage of bleomycin in an esophageal cancer patient.
Sannohe Y; Hirano M; Shirakusa T; Hiratsuka R; Doki K; Inutsuka S
Jpn J Surg; 1979 Dec; 9(4):366-71. PubMed ID: 94614
[TBL] [Abstract][Full Text] [Related]
13. Routine pulmonary function tests during bleomycin therapy. Tests may be ineffective and potentially misleading.
Lewis BM; Izbicki R
JAMA; 1980 Jan; 243(4):347-51. PubMed ID: 6153225
[TBL] [Abstract][Full Text] [Related]
14. Fatal pulmonary fibrosis after a low cumulated dose of bleomycin: role of alpha1-antitrypsin deficiency?
Alliot C; Tabuteau S; Desablens B; Aubry P; Andrejak M
Am J Hematol; 1999 Nov; 62(3):198-9. PubMed ID: 10539931
[No Abstract] [Full Text] [Related]
15. [Lung fibrosis after bleomycin therapy].
Kozielski J; Rauer R; Ziora D; Spychałowicz W
Pneumonol Alergol Pol; 1994; 62(9-10):520-5. PubMed ID: 7532510
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of bleomycin. A Southwest oncology Group study.
Haas CD; Coltman CA; Gottlieb JA; Haut A; Luce JK; Talley RW; Samal B; Wilson HE; Hoogstraten B
Cancer; 1976 Jul; 38(1):8-12. PubMed ID: 59628
[TBL] [Abstract][Full Text] [Related]
17. [Antineoplastic drug-induced pneumonitis-fibrosis].
Oizumi K; Nakai Y; Konno K
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1217-24. PubMed ID: 6206254
[TBL] [Abstract][Full Text] [Related]
18. [Bleomycin pneumonitis].
Kuntár L
Orv Hetil; 1979 Apr; 120(15):903-5. PubMed ID: 86179
[No Abstract] [Full Text] [Related]
19. Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.
Yagoda A; Mukherji B; Young C; Etcubanas E; Lamonte C; Smith JR; Tan CT; Krakoff IH
Ann Intern Med; 1972 Dec; 77(6):861-70. PubMed ID: 4118759
[No Abstract] [Full Text] [Related]
20. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
